Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2,11-diaza--4-(2-(trifluoromethyl)phenyl)-5-(hydroxyaminocarbonyl)-1-((((piperazin-1-yl)carbonyl)methyl)aminocarbonyl)-9-oxa-3,10-dioxocyclopentadecane MeSH Supplementary Concept Data 2025


MeSH Supplementary
2,11-diaza--4-(2-(trifluoromethyl)phenyl)-5-(hydroxyaminocarbonyl)-1-((((piperazin-1-yl)carbonyl)methyl)aminocarbonyl)-9-oxa-3,10-dioxocyclopentadecane
Unique ID
C438587
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C438587
Entry Term(s)
longsycpd2
Registry Numbers
0
Heading Mapped to
*Heterocyclic Compounds, 1-Ring
*Hydroxamic Acids
Frequency
1
Note
a TNF-alpha converting enzyme inhibitor; structure in first source
Source
J Med Chem 2001 Oct 11;44(21):3351-4
Indexing Information
Metalloendopeptidases
Date of Entry
2001/11/06
Revision Date
2002/10/10
2,11-diaza--4-(2-(trifluoromethyl)phenyl)-5-(hydroxyaminocarbonyl)-1-((((piperazin-1-yl)carbonyl)methyl)aminocarbonyl)-9-oxa-3,10-dioxocyclopentadecane Preferred
page delivered in 0.004s